Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström’s Macroglobulinemia

Meletios A. Dimopoulos; Alessandra Tedeschi; Judith Trotman; Ramón García-Sanz; David Macdonald; Veronique Leblond; Beatrice Mahe; Charles Herbaux; Constantine Tam; Lorella Orsucci; M. Lia Palomba; Jeffrey V. Matous; Chaim Shustik; Efstathios Kastritis; Steven P. Treon; Jianling Li; Zeena Salman; Thorsten Graef; Christian Buske

doi:10.1056/NEJMOA1802917

Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström’s Macroglobulinemia

Meletios A. Dimopoulos
, Alessandra Tedeschi
, Judith Trotman
, Ramón García-Sanz
, David Macdonald
, Veronique Leblond
, Beatrice Mahe
, Charles Herbaux
, Constantine Tam
, Lorella Orsucci
, M. Lia Palomba
, Jeffrey V. Matous
, Chaim Shustik
, Efstathios Kastritis
, Steven P. Treon
, Jianling Li
, Zeena Salman
, Thorsten Graef
, Christian Buske

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	The New England Journal of Medicine
Volume	378
Issue number	25
DOIs	https://doi.org/10.1056/NEJMOA1802917
State	Published - Jun 1 2018

Disciplines

Medicine and Health Sciences
Oncology
Survival Analysis
Internal Medicine

Access to Document

10.1056/NEJMOA1802917License: Unspecified

Cite this

Dimopoulos, M. A., Tedeschi, A., Trotman, J., García-Sanz, R., Macdonald, D., Leblond, V., Mahe, B., Herbaux, C., Tam, C., Orsucci, L., Palomba, M. L., Matous, J. V., Shustik, C., Kastritis, E., Treon, S. P., Li, J., Salman, Z., Graef, T., & Buske, C. (2018). Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström’s Macroglobulinemia. The New England Journal of Medicine, 378(25). https://doi.org/10.1056/NEJMOA1802917

Dimopoulos, MA, Tedeschi, A, Trotman, J, García-Sanz, R, Macdonald, D, Leblond, V, Mahe, B, Herbaux, C, Tam, C, Orsucci, L, Palomba, ML, Matous, JV, Shustik, C, Kastritis, E, Treon, SP, Li, J, Salman, Z, Graef, T & Buske, C 2018, 'Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström’s Macroglobulinemia', The New England Journal of Medicine, vol. 378, no. 25. https://doi.org/10.1056/NEJMOA1802917

@article{7394054c9d874ce49a11001bae2d8148,

title = "Phase 3 Trial of Ibrutinib plus Rituximab in Waldenstr{\"o}m{\textquoteright}s Macroglobulinemia",

author = "Dimopoulos, \{Meletios A.\} and Alessandra Tedeschi and Judith Trotman and Ram{\'o}n Garc{\'i}a-Sanz and David Macdonald and Veronique Leblond and Beatrice Mahe and Charles Herbaux and Constantine Tam and Lorella Orsucci and Palomba, \{M. Lia\} and Matous, \{Jeffrey V.\} and Chaim Shustik and Efstathios Kastritis and Treon, \{Steven P.\} and Jianling Li and Zeena Salman and Thorsten Graef and Christian Buske",

note = "Our apologies. An error occurred while setting your user cookie. Please set your browser to accept cookies to continue. NEJM.org uses cookies to improve performance by remembering your session ID when you navigate from page to page. This cookie stores just a session ID; no other information is captured.",

year = "2018",

month = jun,

day = "1",

doi = "10.1056/NEJMOA1802917",

language = "American English",

volume = "378",

journal = "The New England Journal of Medicine",

number = "25",

}

TY - JOUR

T1 - Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström’s Macroglobulinemia

AU - Dimopoulos, Meletios A.

AU - Tedeschi, Alessandra

AU - Trotman, Judith

AU - García-Sanz, Ramón

AU - Macdonald, David

AU - Leblond, Veronique

AU - Mahe, Beatrice

AU - Herbaux, Charles

AU - Tam, Constantine

AU - Orsucci, Lorella

AU - Palomba, M. Lia

AU - Matous, Jeffrey V.

AU - Shustik, Chaim

AU - Kastritis, Efstathios

AU - Treon, Steven P.

AU - Li, Jianling

AU - Salman, Zeena

AU - Graef, Thorsten

AU - Buske, Christian

N1 - Our apologies. An error occurred while setting your user cookie. Please set your browser to accept cookies to continue. NEJM.org uses cookies to improve performance by remembering your session ID when you navigate from page to page. This cookie stores just a session ID; no other information is captured.

PY - 2018/6/1

Y1 - 2018/6/1

UR - https://www.nejm.org/doi/pdf/10.1056/NEJMoa1802917

U2 - 10.1056/NEJMOA1802917

DO - 10.1056/NEJMOA1802917

M3 - Article

VL - 378

JO - The New England Journal of Medicine

JF - The New England Journal of Medicine

IS - 25

ER -

Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström’s Macroglobulinemia

Disciplines

Access to Document

Other files and links

Cite this